PSME3 Antikörper (N-Term)
Kurzübersicht für PSME3 Antikörper (N-Term) (ABIN6757404)
Target
Alle PSME3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with the N-terminal region of the human PA28g protein. On Western blots, it identifies the target band at ~30kD. Reactivity has been confirmed with human MeWo malignant melanoma, A375 malignant melanoma, Jurkat T-lymphocyte. Based on 100 % amino acid conservation at the immunogen sequence, reactivity with mouse, rat, and pig PA28g is also expected.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide derived from the N-terminal region of the human, mouse, rat and pig PA28g (proteosome activator 28g, Ki antigen) protein.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IP, WB (1 - 3 μg/mL)
Usage: Suitable for use in Western Blot, Immunoprecipitation. Western Blot: 1-3 μg/mL. Immunoprecipitation: 7 μg/reaction. Positive control: Human MeWo malignant melanoma, A375 malignant melanoma, Jurkat T-lymphocyte. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.1 % sodium azide, 40 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- PSME3
-
Andere Bezeichnung
- PSME3
-
Hintergrund
-
Name/Gene ID: PSME3
Synonyms: PSME3, Ki), Ki, PA28gamma, Proteasome activator 28-gamma, Proteasome activator subunit 3, REG-GAMMA, PA28 gamma variant 5, Ki antigen, Ki nuclear autoantigen, PA28-gamma, PA28G -
Gen-ID
- 10197
-
UniProt
- P61289
-
Pathways
- Mitotic G1-G1/S Phases, DNA Replication, Positive Regulation of Endopeptidase Activity, Hepatitis C, Synthesis of DNA
Target
-